Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency

D. B. Kohn, K. I. Weinberg, Jan Nolta, L. N. Heiss, C. Lenarsky, G. M. Crooks, M. E. Hanley, G. Annett, J. S. Brooks, A. El-Khoureiy, K. Lawrence, S. Wells, R. C. Moen, J. Bastian, D. E. Williams-Herman, M. Elder, D. Wara, T. Bowen, M. S. Hershfield

Research output: Contribution to journalArticle

454 Citations (Scopus)

Abstract

Haematopoietic stem cells in umbilical cord blood are an attractive target for gene therapy of inborn errors of metabolism. Three neonates with severe combined immunodeficiency were treated by retroviral-mediated transduction of the CD34+ cells from their umbilical cord blood with a normal human adenosine deaminase complementary DNA followed by autologous transplantation. The continued presence and expression of the introduced gene in leukocytes from bone marrow and peripheral blood for 18 months demonstrates that umbilical cord blood cells may be genetically modified with retroviral vectors and engrafted in neonates for gene therapy.

Original languageEnglish (US)
Pages (from-to)1017-1023
Number of pages7
JournalNature Medicine
Volume1
Issue number10
StatePublished - 1995
Externally publishedYes

Fingerprint

Adenosine Deaminase
Fetal Blood
Blood Cells
Blood
Genes
Cells
Gene therapy
Genetic Therapy
Inborn Errors Metabolism
Severe Combined Immunodeficiency
Autologous Transplantation
Hematopoietic Stem Cells
Leukocytes
Complementary DNA
Stem cells
Bone Marrow
Metabolism
Gene Expression
Bone
Severe combined immunodeficiency due to adenosine deaminase deficiency

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Kohn, D. B., Weinberg, K. I., Nolta, J., Heiss, L. N., Lenarsky, C., Crooks, G. M., ... Hershfield, M. S. (1995). Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nature Medicine, 1(10), 1017-1023.

Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. / Kohn, D. B.; Weinberg, K. I.; Nolta, Jan; Heiss, L. N.; Lenarsky, C.; Crooks, G. M.; Hanley, M. E.; Annett, G.; Brooks, J. S.; El-Khoureiy, A.; Lawrence, K.; Wells, S.; Moen, R. C.; Bastian, J.; Williams-Herman, D. E.; Elder, M.; Wara, D.; Bowen, T.; Hershfield, M. S.

In: Nature Medicine, Vol. 1, No. 10, 1995, p. 1017-1023.

Research output: Contribution to journalArticle

Kohn, DB, Weinberg, KI, Nolta, J, Heiss, LN, Lenarsky, C, Crooks, GM, Hanley, ME, Annett, G, Brooks, JS, El-Khoureiy, A, Lawrence, K, Wells, S, Moen, RC, Bastian, J, Williams-Herman, DE, Elder, M, Wara, D, Bowen, T & Hershfield, MS 1995, 'Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency', Nature Medicine, vol. 1, no. 10, pp. 1017-1023.
Kohn DB, Weinberg KI, Nolta J, Heiss LN, Lenarsky C, Crooks GM et al. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nature Medicine. 1995;1(10):1017-1023.
Kohn, D. B. ; Weinberg, K. I. ; Nolta, Jan ; Heiss, L. N. ; Lenarsky, C. ; Crooks, G. M. ; Hanley, M. E. ; Annett, G. ; Brooks, J. S. ; El-Khoureiy, A. ; Lawrence, K. ; Wells, S. ; Moen, R. C. ; Bastian, J. ; Williams-Herman, D. E. ; Elder, M. ; Wara, D. ; Bowen, T. ; Hershfield, M. S. / Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. In: Nature Medicine. 1995 ; Vol. 1, No. 10. pp. 1017-1023.
@article{1776e68373004d36a23940e1147b8f4d,
title = "Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency",
abstract = "Haematopoietic stem cells in umbilical cord blood are an attractive target for gene therapy of inborn errors of metabolism. Three neonates with severe combined immunodeficiency were treated by retroviral-mediated transduction of the CD34+ cells from their umbilical cord blood with a normal human adenosine deaminase complementary DNA followed by autologous transplantation. The continued presence and expression of the introduced gene in leukocytes from bone marrow and peripheral blood for 18 months demonstrates that umbilical cord blood cells may be genetically modified with retroviral vectors and engrafted in neonates for gene therapy.",
author = "Kohn, {D. B.} and Weinberg, {K. I.} and Jan Nolta and Heiss, {L. N.} and C. Lenarsky and Crooks, {G. M.} and Hanley, {M. E.} and G. Annett and Brooks, {J. S.} and A. El-Khoureiy and K. Lawrence and S. Wells and Moen, {R. C.} and J. Bastian and Williams-Herman, {D. E.} and M. Elder and D. Wara and T. Bowen and Hershfield, {M. S.}",
year = "1995",
language = "English (US)",
volume = "1",
pages = "1017--1023",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency

AU - Kohn, D. B.

AU - Weinberg, K. I.

AU - Nolta, Jan

AU - Heiss, L. N.

AU - Lenarsky, C.

AU - Crooks, G. M.

AU - Hanley, M. E.

AU - Annett, G.

AU - Brooks, J. S.

AU - El-Khoureiy, A.

AU - Lawrence, K.

AU - Wells, S.

AU - Moen, R. C.

AU - Bastian, J.

AU - Williams-Herman, D. E.

AU - Elder, M.

AU - Wara, D.

AU - Bowen, T.

AU - Hershfield, M. S.

PY - 1995

Y1 - 1995

N2 - Haematopoietic stem cells in umbilical cord blood are an attractive target for gene therapy of inborn errors of metabolism. Three neonates with severe combined immunodeficiency were treated by retroviral-mediated transduction of the CD34+ cells from their umbilical cord blood with a normal human adenosine deaminase complementary DNA followed by autologous transplantation. The continued presence and expression of the introduced gene in leukocytes from bone marrow and peripheral blood for 18 months demonstrates that umbilical cord blood cells may be genetically modified with retroviral vectors and engrafted in neonates for gene therapy.

AB - Haematopoietic stem cells in umbilical cord blood are an attractive target for gene therapy of inborn errors of metabolism. Three neonates with severe combined immunodeficiency were treated by retroviral-mediated transduction of the CD34+ cells from their umbilical cord blood with a normal human adenosine deaminase complementary DNA followed by autologous transplantation. The continued presence and expression of the introduced gene in leukocytes from bone marrow and peripheral blood for 18 months demonstrates that umbilical cord blood cells may be genetically modified with retroviral vectors and engrafted in neonates for gene therapy.

UR - http://www.scopus.com/inward/record.url?scp=0028864561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028864561&partnerID=8YFLogxK

M3 - Article

VL - 1

SP - 1017

EP - 1023

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 10

ER -